Dow Up 0.17% Nasdaq Up 0.29%

Omeros Corporation (OMER)

-NasdaqGM
14.09 0.75(5.62%) Aug 26, 4:00PM EDT
Prev Close:13.34
Open:13.40
Bid:13.89 x 100
Ask:15.08 x 600
1y Target Est:32.80
Beta:1.27
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:13.40 - 14.32
52wk Range:4.95 - 18.80
Volume:366,898
Avg Vol (3m):400,323
Market Cap:478.99M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMERUp 5.62%478.99M
ACAD2.37B
ALKS6.57B
HRTX283.03M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):889.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.19
Quarterly EPS Est (Sep-14) :-0.64
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback